Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 4 | 1 |
GO:0005849 | mRNA cleavage factor complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A4HKK3
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006379 | mRNA cleavage | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
GO:0098787 | mRNA cleavage involved in mRNA processing | 8 | 1 |
GO:0098789 | pre-mRNA cleavage required for polyadenylation | 9 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0003723 | RNA binding | 4 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
GO:0003729 | mRNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 110 | 112 | PF00675 | 0.744 |
CLV_NRD_NRD_1 | 254 | 256 | PF00675 | 0.741 |
CLV_NRD_NRD_1 | 315 | 317 | PF00675 | 0.810 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.343 |
CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.645 |
CLV_PCSK_KEX2_1 | 219 | 221 | PF00082 | 0.653 |
CLV_PCSK_KEX2_1 | 317 | 319 | PF00082 | 0.816 |
CLV_PCSK_KEX2_1 | 394 | 396 | PF00082 | 0.584 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.331 |
CLV_PCSK_PC1ET2_1 | 112 | 114 | PF00082 | 0.645 |
CLV_PCSK_PC1ET2_1 | 219 | 221 | PF00082 | 0.622 |
CLV_PCSK_PC1ET2_1 | 317 | 319 | PF00082 | 0.816 |
CLV_PCSK_PC1ET2_1 | 394 | 396 | PF00082 | 0.626 |
CLV_PCSK_PC7_1 | 313 | 319 | PF00082 | 0.775 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.399 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.539 |
CLV_PCSK_SKI1_1 | 368 | 372 | PF00082 | 0.531 |
CLV_PCSK_SKI1_1 | 394 | 398 | PF00082 | 0.611 |
DEG_APCC_DBOX_1 | 385 | 393 | PF00400 | 0.608 |
DEG_COP1_1 | 373 | 383 | PF00400 | 0.637 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.688 |
DEG_SCF_FBW7_2 | 342 | 348 | PF00400 | 0.737 |
DEG_SPOP_SBC_1 | 84 | 88 | PF00917 | 0.680 |
DOC_CKS1_1 | 285 | 290 | PF01111 | 0.671 |
DOC_CKS1_1 | 342 | 347 | PF01111 | 0.746 |
DOC_CYCLIN_RxL_1 | 205 | 216 | PF00134 | 0.494 |
DOC_CYCLIN_RxL_1 | 391 | 400 | PF00134 | 0.628 |
DOC_CYCLIN_yCln2_LP_2 | 89 | 95 | PF00134 | 0.748 |
DOC_MAPK_gen_1 | 164 | 172 | PF00069 | 0.611 |
DOC_PP4_FxxP_1 | 176 | 179 | PF00568 | 0.473 |
DOC_PP4_MxPP_1 | 274 | 277 | PF00568 | 0.529 |
DOC_USP7_MATH_1 | 121 | 125 | PF00917 | 0.601 |
DOC_USP7_MATH_1 | 227 | 231 | PF00917 | 0.554 |
DOC_USP7_MATH_1 | 243 | 247 | PF00917 | 0.523 |
DOC_USP7_MATH_1 | 251 | 255 | PF00917 | 0.638 |
DOC_USP7_MATH_1 | 281 | 285 | PF00917 | 0.718 |
DOC_USP7_MATH_1 | 292 | 296 | PF00917 | 0.529 |
DOC_USP7_MATH_1 | 306 | 310 | PF00917 | 0.698 |
DOC_USP7_MATH_1 | 321 | 325 | PF00917 | 0.536 |
DOC_USP7_MATH_1 | 329 | 333 | PF00917 | 0.794 |
DOC_USP7_MATH_1 | 335 | 339 | PF00917 | 0.727 |
DOC_USP7_UBL2_3 | 297 | 301 | PF12436 | 0.791 |
DOC_USP7_UBL2_3 | 304 | 308 | PF12436 | 0.703 |
DOC_WW_Pin1_4 | 105 | 110 | PF00397 | 0.587 |
DOC_WW_Pin1_4 | 117 | 122 | PF00397 | 0.652 |
DOC_WW_Pin1_4 | 284 | 289 | PF00397 | 0.613 |
DOC_WW_Pin1_4 | 341 | 346 | PF00397 | 0.759 |
LIG_14-3-3_CanoR_1 | 174 | 179 | PF00244 | 0.622 |
LIG_14-3-3_CanoR_1 | 193 | 201 | PF00244 | 0.347 |
LIG_14-3-3_CanoR_1 | 368 | 373 | PF00244 | 0.532 |
LIG_14-3-3_CanoR_1 | 4 | 8 | PF00244 | 0.653 |
LIG_14-3-3_CanoR_1 | 85 | 90 | PF00244 | 0.715 |
LIG_BRCT_BRCA1_1 | 8 | 12 | PF00533 | 0.457 |
LIG_FHA_1 | 175 | 181 | PF00498 | 0.531 |
LIG_FHA_1 | 335 | 341 | PF00498 | 0.805 |
LIG_FHA_1 | 369 | 375 | PF00498 | 0.431 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.576 |
LIG_FHA_2 | 258 | 264 | PF00498 | 0.707 |
LIG_FHA_2 | 297 | 303 | PF00498 | 0.547 |
LIG_FHA_2 | 345 | 351 | PF00498 | 0.626 |
LIG_FHA_2 | 59 | 65 | PF00498 | 0.561 |
LIG_FHA_2 | 71 | 77 | PF00498 | 0.561 |
LIG_LIR_Apic_2 | 116 | 121 | PF02991 | 0.695 |
LIG_LIR_Gen_1 | 198 | 209 | PF02991 | 0.479 |
LIG_LIR_Nem_3 | 10 | 16 | PF02991 | 0.437 |
LIG_LIR_Nem_3 | 106 | 110 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 169 | 175 | PF02991 | 0.638 |
LIG_LIR_Nem_3 | 198 | 204 | PF02991 | 0.470 |
LIG_MLH1_MIPbox_1 | 9 | 13 | PF16413 | 0.434 |
LIG_Pex14_2 | 172 | 176 | PF04695 | 0.402 |
LIG_SH2_NCK_1 | 201 | 205 | PF00017 | 0.475 |
LIG_SH3_3 | 124 | 130 | PF00018 | 0.725 |
LIG_SH3_3 | 264 | 270 | PF00018 | 0.786 |
LIG_SH3_3 | 272 | 278 | PF00018 | 0.655 |
LIG_SH3_3 | 339 | 345 | PF00018 | 0.759 |
LIG_SH3_3 | 377 | 383 | PF00018 | 0.670 |
LIG_SUMO_SIM_anti_2 | 14 | 21 | PF11976 | 0.444 |
LIG_SUMO_SIM_anti_2 | 352 | 359 | PF11976 | 0.552 |
LIG_SUMO_SIM_par_1 | 208 | 213 | PF11976 | 0.493 |
LIG_TRAF2_1 | 196 | 199 | PF00917 | 0.564 |
LIG_TRAF2_1 | 61 | 64 | PF00917 | 0.490 |
MOD_CDC14_SPxK_1 | 108 | 111 | PF00782 | 0.520 |
MOD_CDK_SPxK_1 | 105 | 111 | PF00069 | 0.525 |
MOD_CDK_SPxxK_3 | 105 | 112 | PF00069 | 0.526 |
MOD_CK1_1 | 120 | 126 | PF00069 | 0.800 |
MOD_CK1_1 | 284 | 290 | PF00069 | 0.820 |
MOD_CK1_1 | 324 | 330 | PF00069 | 0.742 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.504 |
MOD_CK2_1 | 199 | 205 | PF00069 | 0.625 |
MOD_CK2_1 | 251 | 257 | PF00069 | 0.497 |
MOD_CK2_1 | 296 | 302 | PF00069 | 0.553 |
MOD_CK2_1 | 344 | 350 | PF00069 | 0.638 |
MOD_CK2_1 | 58 | 64 | PF00069 | 0.490 |
MOD_CK2_1 | 70 | 76 | PF00069 | 0.490 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.743 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.592 |
MOD_GlcNHglycan | 229 | 232 | PF01048 | 0.559 |
MOD_GlcNHglycan | 304 | 307 | PF01048 | 0.755 |
MOD_GlcNHglycan | 323 | 326 | PF01048 | 0.801 |
MOD_GlcNHglycan | 327 | 330 | PF01048 | 0.753 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.798 |
MOD_GSK3_1 | 276 | 283 | PF00069 | 0.755 |
MOD_GSK3_1 | 292 | 299 | PF00069 | 0.577 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.535 |
MOD_GSK3_1 | 302 | 309 | PF00069 | 0.791 |
MOD_GSK3_1 | 317 | 324 | PF00069 | 0.681 |
MOD_GSK3_1 | 325 | 332 | PF00069 | 0.723 |
MOD_GSK3_1 | 340 | 347 | PF00069 | 0.620 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.540 |
MOD_N-GLC_1 | 121 | 126 | PF02516 | 0.804 |
MOD_N-GLC_1 | 359 | 364 | PF02516 | 0.547 |
MOD_N-GLC_1 | 36 | 41 | PF02516 | 0.238 |
MOD_NEK2_1 | 296 | 301 | PF00069 | 0.557 |
MOD_NEK2_1 | 370 | 375 | PF00069 | 0.559 |
MOD_NEK2_1 | 69 | 74 | PF00069 | 0.500 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.481 |
MOD_NEK2_2 | 292 | 297 | PF00069 | 0.638 |
MOD_PIKK_1 | 281 | 287 | PF00454 | 0.650 |
MOD_PIKK_1 | 397 | 403 | PF00454 | 0.567 |
MOD_PKA_1 | 317 | 323 | PF00069 | 0.778 |
MOD_PKA_2 | 166 | 172 | PF00069 | 0.631 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.495 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.610 |
MOD_PKA_2 | 312 | 318 | PF00069 | 0.719 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.593 |
MOD_Plk_1 | 36 | 42 | PF00069 | 0.572 |
MOD_Plk_2-3 | 257 | 263 | PF00069 | 0.652 |
MOD_Plk_2-3 | 70 | 76 | PF00069 | 0.591 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.369 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.525 |
MOD_Plk_4 | 335 | 341 | PF00069 | 0.805 |
MOD_Plk_4 | 7 | 13 | PF00069 | 0.455 |
MOD_ProDKin_1 | 105 | 111 | PF00069 | 0.587 |
MOD_ProDKin_1 | 117 | 123 | PF00069 | 0.653 |
MOD_ProDKin_1 | 284 | 290 | PF00069 | 0.614 |
MOD_ProDKin_1 | 341 | 347 | PF00069 | 0.750 |
MOD_SUMO_rev_2 | 213 | 221 | PF00179 | 0.645 |
TRG_DiLeu_BaEn_1 | 217 | 222 | PF01217 | 0.499 |
TRG_DiLeu_BaEn_1 | 353 | 358 | PF01217 | 0.645 |
TRG_DiLeu_BaLyEn_6 | 392 | 397 | PF01217 | 0.483 |
TRG_DiLeu_LyEn_5 | 217 | 222 | PF01217 | 0.601 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.564 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.468 |
TRG_ER_diArg_1 | 110 | 113 | PF00400 | 0.745 |
TRG_ER_diArg_1 | 66 | 68 | PF00400 | 0.561 |
TRG_NLS_Bipartite_1 | 300 | 320 | PF00514 | 0.553 |
TRG_NLS_MonoExtC_3 | 110 | 115 | PF00514 | 0.786 |
TRG_NLS_MonoExtN_4 | 109 | 115 | PF00514 | 0.529 |
TRG_NLS_MonoExtN_4 | 313 | 320 | PF00514 | 0.561 |
TRG_Pf-PMV_PEXEL_1 | 208 | 213 | PF00026 | 0.493 |
TRG_Pf-PMV_PEXEL_1 | 375 | 379 | PF00026 | 0.532 |
TRG_Pf-PMV_PEXEL_1 | 394 | 398 | PF00026 | 0.564 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I4N7 | Leptomonas seymouri | 56% | 100% |
A0A1X0NU71 | Trypanosomatidae | 30% | 100% |
A0A3Q8ITD1 | Leishmania donovani | 83% | 100% |
A0A3R7KNF2 | Trypanosoma rangeli | 35% | 100% |
A4I835 | Leishmania infantum | 83% | 100% |
E9B2Z3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 100% |
Q4Q563 | Leishmania major | 83% | 100% |
V5BKQ1 | Trypanosoma cruzi | 36% | 100% |